1 Min Read
Oct 5 (Reuters) - Eli Lilly and Co :
* Lilly highlights advancements in its oncology portfolio with new data at ESMO 2016 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.